{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations are the most common genetic cause of parkinsonism and that mutations in LRRK2 are linked to dopaminergic neuron loss.",
          "judgment": "Yes",
          "reasoning": "The paper clearly establishes the link between LRRK2 mutations and Parkinson’s disease, specifically focusing on dopaminergic neuron loss as a key feature. This forms a basis for evaluating functional assays."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses transgenic Drosophila over-expressing LRRK2 variants to assess the impact on dopaminergic neuron loss and locomotion deficits. This models the neurodegenerative process observed in Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "Using a model organism to assess neuronal loss and behavioral deficits directly models the key pathological and clinical features of Parkinson's disease, making the assay relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper states that 'transgenic flies harboring G2019S, Y1699C, or G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...'. This implies the use of a wild-type control.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions the use of a wild-type control to compare against the mutant LRRK2 variants.  Replicates are not directly stated, but standard practices in Drosophila genetics would necessitate their use."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study uses several LRRK2 variants (G2019S, Y1699C, G2385R) in comparison to wild-type, enabling a control comparison.",
          "judgment": "Yes",
          "reasoning": "Multiple LRRK2 variants were tested, acting as controls against each other and the wild-type protein. This allows for a better assessment of the effect of each specific mutation."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports 'late-onset loss of dopaminergic (DA) neurons' and 'locomotion deficits' in the mutant flies, but does not include specific statistical analyses or OddsPath calculations.",
          "judgment": "No",
          "reasoning": "While the paper describes phenotypic effects, it does not present statistical tests, p-values, or calculations of OddsPath, indicating insufficient statistical analysis for a quantitative assessment."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three mutant variants (G2019S, Y1699C, G2385R) and a wild-type control, resulting in a total of four variants tested.",
          "judgment": "N/A",
          "reasoning": "With fewer than 11 total variants, the functional evidence strength remains at a supporting/moderate level."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant causes dopaminergic neuron loss and locomotion deficits in a Drosophila model, supporting its role in LRRK2-related parkinsonism, but the lack of quantitative statistical analysis limits the strength of the evidence to 'supporting'."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations are the most common genetic cause of parkinsonism and that mutations in LRRK2 are linked to dopaminergic neuron loss.",
          "judgment": "Yes",
          "reasoning": "The paper clearly establishes the link between LRRK2 mutations and Parkinson’s disease, specifically focusing on dopaminergic neuron loss as a key feature. This forms a basis for evaluating functional assays."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses transgenic Drosophila over-expressing LRRK2 variants to assess the impact on dopaminergic neuron loss and locomotion deficits. This models the neurodegenerative process observed in Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "Using a model organism to assess neuronal loss and behavioral deficits directly models the key pathological and clinical features of Parkinson's disease, making the assay relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper states that 'transgenic flies harboring G2019S, Y1699C, or G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...'. This implies the use of a wild-type control.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions the use of a wild-type control to compare against the mutant LRRK2 variants.  Replicates are not directly stated, but standard practices in Drosophila genetics would necessitate their use."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study uses several LRRK2 variants (G2019S, Y1699C, G2385R) in comparison to wild-type, enabling a control comparison.",
          "judgment": "Yes",
          "reasoning": "Multiple LRRK2 variants were tested, acting as controls against each other and the wild-type protein. This allows for a better assessment of the effect of each specific mutation."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports 'late-onset loss of dopaminergic (DA) neurons' and 'locomotion deficits' in the mutant flies, but does not include specific statistical analyses or OddsPath calculations.",
          "judgment": "No",
          "reasoning": "While the paper describes phenotypic effects, it does not present statistical tests, p-values, or calculations of OddsPath, indicating insufficient statistical analysis for a quantitative assessment."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three mutant variants (G2019S, Y1699C, G2385R) and a wild-type control, resulting in a total of four variants tested.",
          "judgment": "N/A",
          "reasoning": "With fewer than 11 total variants, the functional evidence strength remains at a supporting/moderate level."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Y1699C variant causes dopaminergic neuron loss and locomotion deficits in a Drosophila model, supporting its role in LRRK2-related parkinsonism, but the lack of quantitative statistical analysis limits the strength of the evidence to 'supporting'."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations are the most common genetic cause of parkinsonism and that mutations in LRRK2 are linked to dopaminergic neuron loss.",
          "judgment": "Yes",
          "reasoning": "The paper clearly establishes the link between LRRK2 mutations and Parkinson’s disease, specifically focusing on dopaminergic neuron loss as a key feature. This forms a basis for evaluating functional assays."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses transgenic Drosophila over-expressing LRRK2 variants to assess the impact on dopaminergic neuron loss and locomotion deficits. This models the neurodegenerative process observed in Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "Using a model organism to assess neuronal loss and behavioral deficits directly models the key pathological and clinical features of Parkinson's disease, making the assay relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper states that 'transgenic flies harboring G2019S, Y1699C, or G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons...'. This implies the use of a wild-type control.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions the use of a wild-type control to compare against the mutant LRRK2 variants.  Replicates are not directly stated, but standard practices in Drosophila genetics would necessitate their use."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study uses several LRRK2 variants (G2019S, Y1699C, G2385R) in comparison to wild-type, enabling a control comparison.",
          "judgment": "Yes",
          "reasoning": "Multiple LRRK2 variants were tested, acting as controls against each other and the wild-type protein. This allows for a better assessment of the effect of each specific mutation."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports 'late-onset loss of dopaminergic (DA) neurons' and 'locomotion deficits' in the mutant flies, but does not include specific statistical analyses or OddsPath calculations.",
          "judgment": "No",
          "reasoning": "While the paper describes phenotypic effects, it does not present statistical tests, p-values, or calculations of OddsPath, indicating insufficient statistical analysis for a quantitative assessment."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses three mutant variants (G2019S, Y1699C, G2385R) and a wild-type control, resulting in a total of four variants tested.",
          "judgment": "N/A",
          "reasoning": "With fewer than 11 total variants, the functional evidence strength remains at a supporting/moderate level."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2385R variant causes dopaminergic neuron loss and locomotion deficits in a Drosophila model, supporting its role in LRRK2-related parkinsonism, but the lack of quantitative statistical analysis limits the strength of the evidence to 'supporting'."
    }
  ]
}